Biopharm Levo Injection should only be administered by intravenous infusion. It is not for intramuscular, intrathecal, intraperitoneal, or subcutaneous administration. The dosage depends on the type and severity of the infection and the sensitivity of the presumed causative pathogen. The duration of therapy varies according to the course of the disease. As with antibiotic therapy in general, administration of Biopharm Levo Injection should be continued for a minimum of 48 to 72 hours after the patient has become afebrile. It is usually possible to switch from initial intravenous treatment to the oral route after a few days.
The usual dose is 500mg administered by slow infusion over 60 minutes every 24 hours or 750mg administered by slow infusion over 90 minutes every 24 hours, as described in the following dosing table. (See Tables 1 and 2.)
Click on icon to see table/diagram/image
Click on icon to see table/diagram/image